SCHEMBL15065372

SCHEMBL15065372

CCOCCCCNCCC(C)CC1(c2ccc(C)cc2)CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 9/20 0.53
SLC6A3 Q01959 9/20 0.53
SLC6A4 P31645 8/20 0.53
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 1/20 0.33
CHRM2 P08172 2/20 0.32
CHRM1 P11229 1/20 0.32
DRD2 P14416 1/20 0.32
DRD4 P21917 1/20 0.32
DRD3 P35462 1/20 0.32
POLB P06746 1/20 0.31
THRB P10828 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15065924 0.91 SLC6A2 (0.52) SLC6A2SLC6A3SLC6A4KDM4EALDH1A1
SCHEMBL15066031 0.90 SLC6A3 (0.52) SLC6A2SLC6A3SLC6A4KDM4EPOLB
SCHEMBL15065487 0.86 SLC6A2 (0.48) SLC6A2SLC6A3SLC6A4KDM4EALDH1A1
SCHEMBL15066246 0.85 SLC6A3 (0.56) SLC6A2SLC6A3SLC6A4KDM4EPOLB
SCHEMBL15065551 0.82 SLC6A3 (0.67) SLC6A2SLC6A3SLC6A4
SCHEMBL15065883 0.81 SLC6A2 (0.52) SLC6A2SLC6A3SLC6A4KDM4EALDH1A1
SCHEMBL15066381 0.80 SLC6A3 (0.55) SLC6A2SLC6A3SLC6A4KDM4EHPGD
SCHEMBL15065898 0.79 SLC6A3 (0.53) SLC6A2SLC6A3SLC6A4CHRM2CHRM1
SCHEMBL15066416 0.79 SLC6A3 (0.53) SLC6A2SLC6A3SLC6A4KDM4EALDH1A1
SCHEMBL15066503 0.78 SLC6A2 (0.53) SLC6A2SLC6A3SLC6A4KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2797870-A1 COMPOSITIONS, SYNTHESIS, AND METHODS OF USING PHENYLCYCLOALKYLMETHYLAMINE DERIVATIVES Reviva Pharmaceuticals, Inc. (US) 2014-11-05 EP disclosed
WO-2013102195-A1 COMPOSITIONS, SYNTHESIS, AND METHODS OF USING PHENYLCYCLOALKYLMETHYLAMINE DERIVATIVES REVIVA PHARMACEUTICALS, INC. (US) 2013-07-04 WO disclosed